Connection

Cristina Gervasoni to HIV-1

Back to Details
This is a "connection" page, showing publications Cristina Gervasoni has written about HIV-1.
Cristina Gervasoni
Connection Strength
0.247
HIV-1
  1. Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice. Antivir Ther. 2018; 23(3):249-257.
    View in: PubMed
    Score: 0.060
  2. Effects of ritonavir and cobicistat on dolutegravir exposure: when the booster can make the difference. J Antimicrob Chemother. 2017 06 01; 72(6):1842-1844.
    View in: PubMed
    Score: 0.058
  3. Pregnancy-related changes of antiretroviral pharmacokinetics: an argument for therapeutic drug monitoring. Antivir Ther. 2017; 22(4):361-363.
    View in: PubMed
    Score: 0.056
  4. Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect? Antivir Ther. 2017; 22(4):353-356.
    View in: PubMed
    Score: 0.056
  5. Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data. Ther Drug Monit. 2019 02; 41(1):59-65.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.